rawfin.tv
Phio Pharmaceuticals Corp. Enterprise Value to Forward Revenue Detailed
MarketsstocksAI Generated

Phio Pharmaceuticals Corp. Enterprise Value to Forward Revenue Detailed

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

This article presents detailed financial information for Phio Pharmaceuticals Corp., specifically focusing on its enterprise value to forward revenue ratio. The data provides a key valuation metric for investors assessing the company's financial health and future prospects.

BiotechnologyValuationFinancial MetricsEnterprise ValueRevenue

Related Articles

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks